4th Apr 2008 07:01
Victrex PLC04 April 2008 4 April 2008 Victrex plc Half Year Trading Update The Company announces its trading update for the six months ended 31 March 2008. Trading in the first half has continued in line with expectations. We haveachieved further sales growth, with record first half sales volume ofapproximately 1,293 tonnes, some 6% ahead of the second half of last year (1,222tonnes) and in line with the previous first half of 1,286 tonnes. •United States volume showed continued growth at 418 tonnes which was 4% ahead of last year's second half of 402 tonnes and 7% ahead of the previous first half of 389 tonnes. •European sales volume saw a return to growth at 646 tonnes, which was 10% up on the second half of last year (587 tonnes) and close to the previous first half (656 tonnes). •Asia-Pacific sales volume was maintained at 229 tonnes, in line with the second half of last year (233 tonnes) and 5% below the previous first half (241 tonnes). •At approximately £11.7m, revenues of Invibio(R), the medical implant materials business, continued to show good growth, up by 19% on last year's second half of £9.8m and by 23% on the previous first half of £9.5m. The announcement of the Company's results for the six months ended 31 March 2008will be made on Tuesday, 20 May 2008. -Ends- For further information please contact: Victrex plc 01253 897700Michael Peacock, Finance DirectorHogarth Partnership Limited 0207 357 9477Nick Denton / Barnaby Fry Victrex plc is an innovative, world leader in high performance materials throughthe manufacture of VICTREX(R) PEEK(TM) polymer, a high performance, easy to process thermoplastic. VICTREX PEEK has a unique combination of chemical, wear, electrical, hydrolysisand temperature resistance, as well as excellent dimensional, mechanical andchemical stability combined with inherent purity and low flammability. End users specify VICTREX PEEK to reduce systems costs, improve partperformance, exploit greater design freedom and create a differentiatedapplication. VICTREX PEEK is used across a broad range of applications indiverse markets including transport, industrial, electronics and medical.Invibio(R), Victrex's biomaterial business, provides specialised solutions formedical device manufacturers. The Group's headquarters are in the UK where its manufacturing facilities arebased. This is complemented by a global network of sales, distribution andtechnical centres that serve more than 30 countries worldwide. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Victrex